Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more
Impact factor 2022
3.8
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2022
6.3
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2022
0.859
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2022
0.989
View more metrics
Hide
Articles in press

Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis
Luis Vega, Daniela Simian, Abraham I. Gajardo, Marcelo Salinas, Andrea Urra, Máximo Cattaneo, Rosario Pino, Juan P. Roblero, ... Jaime Poniachik
Full text access
Uncorrected Proof. Available online 10 May 2024
Prognostic significance of low hepatic fat content in advanced chronic liver disease: MRI-PDFF insights
Atsushi Nakamura, Tsubasa Yoshimura, Takeshi Ichikawa, Keiji Okuyama
Full text access
Uncorrected Proof. Available online 10 May 2024
Spending on nucleos(t)ide analogues for hepatitis B in medicaid beneficiaries: 2012-2021
Stephen E. Congly, Mayur Brahmania, Carla S. Coffin
Full text access
Uncorrected Proof. Available online 10 May 2024
View all Ahead of print
Current Issue
Issue
Vol. 29. Issue 3.
(May - June 2024)
Editorial board
Ann Hepatol. 2024;29:101504
Full text access
Editorial
The 2023 meeting of the Latin American Association for the Study of the Liver: A summary and looking ahead
Francisco Javier Valentin-Cortez, Norberto Chávez-Tapia
Ann Hepatol. 2024;29:101476
Full text access
Opinions
Liver rupture in patients with amyloidosis: Clinical features and treatment
Xiangyu Du, Liangzhi Wen, Bin Wang, Dongfeng Chen, Wei Wang
Ann Hepatol. 2024;29:101500
Full text access
Concise reviews
Pathophysiology of ascites: The importance of the intestine. A surgical contribution to the understanding of a medical problem
Gabriel E. Gondolesi, Carolina Rumbo, Leonardo Montes, Lucia Novellis, Diego Ramisch, Ariel Riquelme Henríquez, Mariana Ortega, Federico Viano, ... Héctor Solar
Ann Hepatol. 2024;29:101498
Full text access
View all issue
Issues in progress
View all issues in progress
Archive
View all archive
Supplements
View all supplements
Instructions for authors
Special content about COVID-19
Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
Ana Barreira-Díaz, Mar Riveiro-Barciela, Eva María Fernández-Bonilla, Vanesa Bernal, Agustín Castiella, Marta Casado-Martín, Carolina Delgado, María-Carlota Londoño, Álvaro Díaz-González, Indhira Pérez-Medrano, Andrés Conthe, Margarita Sala, Beatriz Mateos, Judith Gómez-Camarero, Dolores Antón-Conejero, Carmen Del Pozo-Calzada, Francisca Cuenca, Ares Villagrasa-Vilella, Magdalena Salcedo
10.1016/j.aohep.2024.101489
Ann Hepatol. 2024;29:
Full text access
Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
Shuguang Pan, Ying Hu, Lang Gan, Jiejuan Lai, Ping Zheng, YuJun Zhang, Ling Shuai, Yan Jiang, Mo Chen, Junping Wang, Yu He
10.1016/j.aohep.2023.101279
Ann Hepatol. 2024;29:
Full text access
View all COVID-19 artciles
Most often read
Manuel Mendizabal, Guilherme Grossi Lopes Cançado, Agustín Albillos
10.1016/j.aohep.2023.101180
Ann Hepatol. 2024;29:
This article has been read 3.969 times
View all Most Often read articles
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos